Genetic Diseases Flashcards
Duchenne Muscular Dystrophy - Inheritance
X-linked Recessive
Affects 1/3000 males
Duchenne Muscular Dystrophy - Clinical Presentation
Onset before 5 yrs, wheelchair by 13, median age of death is 30 years.
Progressive myopathy; large calves, gowers maneuver, cardiac compromise, abnormal gait, 10X creatine Kinase levels
Duchenne Muscular Dystrophy - Mechanism
DMD (dysrophin) mutation on Ch Xp12.2
Absence of Dystrophin
Loss of function due to large deletions of exons, nonsense frameshift mutations
High new mutation rate due to largest gene in genome.
DMD associated dilated cardiomyopathy
early death
dilated cardiomyopathy presenting between 20-40
no skeletal involvement
milder symptoms
Hereditary Neuropathy with Liability to Pressure Paulsy - Inheritance
Autosomal Dominant
Hereditary Neuropathy with Liability to Pressure Paulsy - Clinical Presentation
Temporary neuropathy when pressure is applied; limgs can go to sleep for longer periods of time.
First attack in 2nd grade
Recovery is incomplete and leads to disability
Hereditary Neuropathy with Liability to Pressure Paulsy - Disease mechanism
Loss of function of PMP22 ch 17 due to unequal crossing over
PMP22 is integral glycoprotein in nerves
Osteogenesis Imperfecta Type I - inheritance
Autosomal Dominant
1/30,000 to 50,000
Osteogenesis Imperfecta Type I - Clinical Presentation
Variable expressivity
Multiple fractures, short stature, adult onset hearing loss, blue sclerae
Osteogenesis Imperfecta Type I - Mutation
Loss of Function
Non-sense frameshift mutation of COL1A1 ch17 causes pre-mature termination
mRNA to be degraded, so less collagen can be made
Charcot Marie Tooth Type 1A - inheritance
Autosomal Dominant
fully penetrant
variable expressivity
Charcot Marie Tooth Type 1A - Clinical Presentation
Demyelination of motor and sensory neurons lower extremity weakness muscle atrophy foot deformity - hammertoes progressive
Charcot Marie Tooth Type 1A - Mechanism
Gain of function - demyelination
duplication of PMP22 gene 17p11.2
Osteogenesis Imperfecta Type II, III and IV - Inheritance
Autosomal Dominant
Osteogenesis Imperfecta Type II, III and IV - Clinical Presentation
More severe form
Brittle bones, increased fractures, blue sclerae
Osteogenesis Imperfecta Type II, III and IV - Mechanism
Novel Property Mutation
COL1A2 ch 7 protein is mutated with different folding forming collagen trimers that are mutated.
Huntington Disease - Inheritance
Autosomal Dominant 1/10,000 Anticipation Early onset - parental Later onset - maternal
Huntington Disease - Clinical Presentation
Progressive neurodegenerative disorder with adult onset motor, cognitive, and psychiatric disturbances
death 15 years after onset
Huntington Disease - Mechanism
Tri nucleotide CAG repeats in HTT ch 4 huntingtin gene exon
number of repeats corresponds to age of onset.
Myotonic Dystrophy 1 - inheritance
Autosomal Dominant
Myotonic Dystrophy 1 - Clinical Presentation
Droopy eye, intellectual difficutly, hypotonia
Myotonic Dystrophy 1 - Mechanism
Increased CTG repeats in 3’ UTR of DMPK ch 15 gene
Correspond to age of onset and progression
Phenylketouria - inheritance
Autosomal Recessive
1/10,000
carrier frequency of 1/50 in Northern European
Phenylketouria - Clinical Presentation
Epilepsy, mental retardation, hyperactivity, tremor, gait disorders
High Phe is toxic to CNS
PKU Mechanism
Paritial or complete loss of function
Over 400 alleles identified and most compound heterozygotes.
1) defect in pAH gene encoding phenylalanin hydorxylase that catalyzes Phe –> Tyr
2) 1-3% mutation in BH4 synthesis or regeneration
BH4 mutation
PKU mutation
causes decreased levels of serotonin and dopamine as well
PKU treatment
Low-Phe diet should be maintained all life.
BH4 deficient should be treated with oral BH4 and supplemented with NTs.
Maternal PKU
maintain low Phe-diet during childbearing years and pregnancy.
Not on low Phe diet, give birth to malformed children and mental retardation even without genotype.
Due to Phe passing BBB and preventing necessary materials from accessing brain.
Newborn Screening of PKU
Mass Spec to sort by size and charge.
Compare normal [Phe] to [tyr]
Must be done enough after birth but before CNS is affected.
Alpha1-Antitrypsin Deficiency - Inheritance
Autosomal Recessive
More common in N. Europeans
1/2500 affected
1/25 carriers
Alpha1-Antitrypsin Deficiency - Clinical
Emphysema, liver cirrhosis/cancer due to accumulation of misfolded alpha1-AT proteins
Alpha1-Antitrypsin Deficiency - Mechanism
Defective alpha-1-AT protein
smoking accelerates disease
Z allele (Glu342Lys) expresses misfolded protein that aggregates in ER of liver to cuase liver damage.
S allel (Glu264Val) expresses an unstable protein that is less effective.
Alpha1-Antitrypsin Deficiency - Treatment
Treatment of COPD by bronchodilators, vaccinations against flu and pnemonia, pulmonary rehab, lung transplant
Developing treatments: enzyme repalcement therapy, gene thearpy, release misfolded AAT into blood.
Alpha1-Antitrypsin
ATT (SERPINA1)
made in liver
serine protease inhibitor that binds to elastase and inhibits it.
Elastase
inhibited by ATT
destroys connected tissue in lung (elastin) to cause emphysema
Made by neutrophils and allows mobilization of lung cells to promote healing.
LTB4
secreted from macrophages in lung to make attract neutrophils to make more elastase.
Tay-Sachs Disease - Inheritance
Autosomal Recessive
1/360,000
1/3,6000 A Jews
Tay-Sachs Disease - Clinical Presentation
Progressive degeneration of CNS, onset at 3-6 months
muscle weakness, loss of voluntary movement, seizures
Eye abnormality/visual loss - cherry red spot
Tay-Sachs Disease - Mechanism
Lysosomal storage disease
Defect in alpha subunit (HEXA on Ch1 5) of Hexoamidinidase A that degrades GM2 ganglioside.
Most common mutation is a 4bp insertion in exon 11 of HEXA
Sandhoff Disease - Inheritance
Autosomal Recessive
Sandhoff Disease - Clinical Presentation
Similar to Tay-Sachs, but more severe
Defects in HEXB CH 5 makingbeta subunit in HexA and HexB inative
Sandoff vs. Tay-Sachs
TS only has mutation in HexA
S: mutation in HexA and HexB due to defective Beta subunit
AB variant of Tay-Sachs
rare form where both HexA and HexB are normal, but GM2 accumulates due to defect in GM2 activator protein that facilitates interaction between GM2 and HexA enzyme.
Cystic Fibrosis - Clinical Presentation
Salty skin, poor growth and weight gain despite normal food intake
accumulation of thick, sticky mucus, frequent chest infections, coughing
Cystic Fibrosis - Mechanism
mutation in CFTR gene (ch 7) needed to regulate sweat, digestive juice and mucus by regulating Na/K channels across epithelial
Hereditary Hemachromatosis - inheritance
Autosomal Recessive
Hereditary Hemachromatosis - Clinical Presentation
Hepatic cirrhosis in combo with hypopituitarism, cardiomyopathy, diabetes, arthritis, hyperpigmentation
iron overload
Hereditary Hemachromatosis - mechansim
mutation in HFE gene on Ch 6
important in iron regulation
Achondroplasia - Inheritance
Autosomal Dominant
1/15,000-40,000
80% new mutation (1138)
100% penetrance
Achondroplasia - Clinical Pres
Small stature (4'3" and 4') Rhizomelic limb shortening, short fingers, genu varum, trident hands, large head, frontal bossing, small foramen magnum
Achondroplasia - Mechanism
Gain of Function
Gly380Arg in FGFR3 (CH 4) Gene
Regulates bone growth by limited formation of bone from cartilage.
Retinoblastoma - Inheritance
Autosomal Dominance
1/15000
incomplete penetrance
Retinoblastoma - Clinical Presentation
malignant tumor of retina
Absence of red retina
strabismus, visual deterioration
Retinoblastoma- Mechanism
Mutation in RB1 gene Ch13
RB is a tumor supressor
Loss of function - destabilize or cant associated with enzymes for deacytylation
Neurofibromatosis Type I - Inheritance
Autosomal Dominant 1/3000 50% new mutation rate Variable expressivity extreme pleiotropy
Neurofibromatosis Type I - Clinical Presentation
Cafe au lait, axillary and inguinal freckling, multiple neurofibromas, lisch nodules (spots.bumps on eyes)
Neurofibromatosis Type I - Mechanism
Mutation on NF1 Ch17
NF1 regulates cell proliferation and is a tumor suppressor
Loss of function
Must have mutation on both genes to show phenotype
Tuberous Sclerosis - inheritance
Autosomal Dominant 1/6000 Variable expressivity 1/3 inherited; 2/3 de novo fully penetrant
Tuberous Sclerosis - clinical Presentation
Hypopigmented patches, angiofibroma, shangreen patch, renal cysts, lymphangiolelomyomatosis, cardiac rhabdomyoma, CNS issues, seizures, ADHD cognitive disorders
Tuberous Sclerosis - mechanism
Mutation in TSC1 or TSC2
encode hemartin and tuberin porteins that regulate cell growth and proliferation
on Ch9 and 16
Loss of function mutations
Marfan Syndrome - inheritance
AD
1.5000 births
25% new mutation
variable expressivity
Marfan Syndrome - Clinical Presentation
connective tissue disorder in aorta, ocular, skeletal, and cardio
aoritc root enlargement, ectopia lentis, scoliosis, pectus excavatum
Marfan - mechanism
FBN1 fibrillin - an extracellular matrix proin on Ch15
Negative activity mutation
Severe reduction in #
AD Polycystic Kidney Disease - Inheritance
AD
1/1000
AD Polycystic Kidney Disease - Clinical
Enlarged kidney with multiple cysts, end stage renal disease, renal cysts in other organs, intracranial aneurysms
AD Polycystic Kidney Disease - mechanism
ADPKD-1 mutation on Ch16 on Ch4
Locus heterogeneity
Familial Hypercholesterolemia - inheritance
AD
1/500
Familial Hypercholesterolemia - Clinical Presentation
High cholesterol
deposits of cholesterol throughout body
premature coronary artery disease
Familial Hypercholesterolemia - mechaism
Mutation in gene encoding LDL receptor (cant clear LDL from blood stream)
Fragile X-Syndrome - Inheritance
X-linked Dominant
1:2500-4000 in males
1/7000-8000 in males
Anticipatory and maternal bias
Fragile X-Syndrome - Clinical Presentation
Mental deficiency, large ears and long face, macroorchism (enlarged testicles), autism like, hand flapping/biting
Fragile X-Syndrome - Mechansim
Trinucleotide repeats over 200 in FMR1 in 5’ UTR due to hypermethylation and silencing.
Fragile X-associated Tremor/Ataxia Syndrome - mechanism
from fragile X premutation (59-200 CGG repeats) that aren’t hypermethylated but make more RNA
Fragile X-associated Tremor/Ataxia Syndrome - Clinical Presentation
Parkinson like features, gait ataxis, premature ovarian failure in women